Chitosan nanoparticles as a nasal drug delivery for memantine hydrochloride

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 1, 2015, Pages 34-37

  Joysa Ruby, J ^a   Pandey, V P ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Chitosan; Memantine hydrochloride; Nanoparticles; Tripolyphosphate

Indexed keywords

CHITOSAN; MEMANTINE; NANOPARTICLE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; EXCIPIENT COMPATIBILITY; GELATION; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NASAL DRUG DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POLYDISPERSIBLITY INDEX; ZETA POTENTIAL;

EID: 84920263566     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. T Lopez Leon, ELS Carvalho, B Seijo, JL Ortega Vinuesa, D Bastos-Gonzalez. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 2005;283(2):344–51.
2. Y Kawashima, T Handa, H Takenaka, SY Lin, Y Ando. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. J Pharm Sci 1985;74(3):264–8.
3. Y Kawashima, T Handa, A Kasai, H Takenaka, SY Lin. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. Chem Pharm Bull 1985;33(6):2469–74.
4. P Calvo, C Remunan Lopez, JL Vila Jato, MJ Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997;63(1):125–32.
5. TK Vyas, A Shahiwala, S Marathe, A Misra. Intranasal drug delivery for brain targeting Curr Drug Delivery 2005;2:165–75.
6. L Illum. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 2000;11:1–18.
7. L Illum. Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 2004;56:3–17.
8. RG Thorne, WH Frey. Delivery of neurotrophic factors to the central nervous system. Clin Pharmacokinet 2001;40:907–46.
9. Jon W Johnson, Shawn E Kotermanski. Mechanism of action of memantine. Curr Opin Pharmacol 2006;6(1):61–7.
10. C Christodoulou, P Melville, WF Scherl. Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 2006;(1-2):245-50.
11. S Bhavna, M Md Ali. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm 2013;40(2):278-87.
12. Ford JL, P Timmins, MH Rubinstein. Pharmaceutical thermal analysis. Ellis Horwood, Chichester; 1989. p. 201-37.
13. Ford JL, Freisurg. Symposium on pharmacy and thermal analysis; 1993. p. 2.
14. Ahmad, Md Zaki, Kumar Vijay, Kumar Atul, Akhter Sohail. Drug-Excipient (s) interactions and compatibility study: a review. J Pharm Res 2010;3(9):2092.
15. Sonali S Bharate, Sandip B Bharate, Amrita N Bajaj. Interactions and compatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excipients Food Chem 2010;1(3):3.
16. Giron D. Application of thermal analysis in the pharmaceutical industry. J Pharm Biomed Anal 1986;4(6):755-70.
17. Swamivelmanickam M, Manavalan R, Valliappan K. Selection of excipients for orally disintegrating tablets of olanzapine through drug excipient compatibility testing. J Pharm Res 2011;4(4):1056-9.
18. Dubernet C. Thermoanalysis of microspheres. Thermchim Acta 1995;248:259-69.
19. Nanjwade BK, Manjappa AS, Murthy RSR, Pol YD. A novel pH triggered in sit gel for sustained ophthalmic delivery of ketorolac trimethamine. Asian J Pharm Sci 2009;4(3):189-99.
20. Jain NK, Ram A. Development and Characterization of nanostructured lipid carriers of oral hypoglycemic agent: selection of surfactants. Int J Pharm Sci Rev Res 2011:7(2):125-30.
21. Mura P, MT Fancci, A Manderioli, G Bramante, L ceccarelli. Multivariate calibration: application of pharmaceutical analysis. J Pharm Biomed Anal 1998;18:151-63.
22. Tonder ECV, AP Lotter, SA Botha. Compatibility of nateglinide with excipients in immediate release tablets. Drug Dev Ind Pharm 1990;16:2125-33.